Building a Global Research Network: Chronic Kidney Disease as a Public Health Crisis
At least 20% of people aged 65 to 74, and 50% of people over 75, have chronic kidney disease. However,…
Missed Revenue in Clinical Research: 1 Study, 10 Sites, $154,000 Caught
Whether from faulty sponsor payment systems, incomplete invoicing, or other causes, private practice investigational sites routinely miss out on significant…
Access to Patients = Exceeded Enrollment
See how Frenova’s clinical research sites, through rapid startup, leveraged relationships and site management achieved enrollment goals in less time…
Chronic Kidney Disease Expertise
Success in chronic kidney disease clinical trials requires collaboration and close relationships with investigators who understand and provide care to…
The Burden of Research on Physician Practices: Is Relief in Sight?
Engaging in clinical research offers many advantages to private physicians. Providing the best possible patient care with the widest possible…
Research as a Standard Offering for People with Kidney Disease
Kidney disease research is under-funded and, compared with research in other disciplines — oncology and infectious disease, for instance —…
Start with the Patient in Mind® – Interview With Patient Partner Donnie King
Start with the patient in mind — let’s renew our resolve to represent those who participate in studies to advance…
Overcoming Barriers to Enrolling Renal Patients in Clinical Trials: Q&A With Kurt Mussina
Kurt Mussina, General Manager of Frenova Renal Research and Vice President of Clinical Studies Operations for Fresenius Medical Care North…
Research as Care
Speed is key in bringing new drugs to patients. Speed in clearing regulatory hurdles, gearing up to product launch, gaining…
F1RST Up®: Accelerating Clinical Trial Start-Up
Despite the pressing need to bring novel therapies to patients with renal impairments, the development time and cost to bring…